Tower Research Capital (TRC)’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
Other funds holding IMPV
EC
CS
WIC
GLAM
BCM
AAM
Tower Research Capital (TRC)'s IMPV Position: Q4 2018 in Review
Tower Research Capital (TRC) sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 896 shares — an estimated $41K sold.
Tower Research Capital (TRC) first reported a position in IMPV in Q2 2013 and held it in 15 quarters. The position peaked at $149K in Q3 2013. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.
- Tower Research Capital (TRC) reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
- Tower Research Capital (TRC) sold 896 Imperva, Inc. shares in Q4 2018, an estimated $41K.
- Tower Research Capital (TRC) first reported a position in Imperva, Inc. in Q2 2013 and held it in 15 quarters.
- Tower Research Capital (TRC)'s Imperva, Inc. position peaked at $149K in Q3 2013.
- 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.